Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group - Top-Institutions - MDSpire

Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group

  • By

  • J Hillengass

  • L A Moulopoulos

  • S Delorme

  • V Koutoulidis

  • J Mosebach

  • T Hielscher

  • M Drake

  • S V Rajkumar

  • B Oestergaard

  • N Abildgaard

  • M Hinge

  • T Plesner

  • Y Suehara

  • K Matsue

  • N Withofs

  • J Caers

  • A Waage

  • H Goldschmidt

  • M A Dimopoulos

  • S Lentzsch

  • B Durie

  • E Terpos

  • August 25, 2017

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology/Oncology
    • Radiology
    • Multiple Myeloma Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology/Oncology
    • Radiology
    • Myeloma Clinical Research

  • #3

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology/Oncology
    • Radiology
    • Multiple Myeloma Research

  • #4

    University of Heidelberg
    University of Heidelberg

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Hematology/Oncology
    • Radiology
    • Myeloma Imaging Research

  • #5

    University College London Hospitals (UCLH)
    University College London Hospitals (UCLH)

    London, England

    Key Differentiators

    • Hematology/Oncology
    • Radiology
    • Multiple Myeloma Imaging

Original Source(s)

Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group

  • by J Hillengass, L A Moulopoulos, S Delorme, V Koutoulidis, J Mosebach, T Hielscher, M Drake, S V Rajkumar, B Oestergaard, N Abildgaard, M Hinge, T Plesner, Y Suehara, K Matsue, N Withofs, J Caers, A Waage, H Goldschmidt, M A Dimopoulos, S Lentzsch, B Durie, E Terpos

  • August 25, 2017

Related Content

Evaluating Hypoalbuminemia as a Prognostic Indicator in Monoclonal Gammopathy of Undetermined Significance (MGUS) within Its Biological Framework

Infection incidence, timing, and predictors in newly diagnosed multiple myeloma: a real-world retrospective cohort study

Case Report: A diagnostic chameleon of EBV-associated immune dysregulation: HLH unmasking multiple myeloma with subsequent emergence of aggressive B-cell lymphoma